NR3C1 and breast cancer: More studies are needed to further explore the utility of tracking either pS143-GR or pS134-GR gene signatures as potential biomarkers of advanced cancer behaviors (i.e., p38 MAPK-mediated tumor cell dissemination) in breast cancer patient subpopulations.